About Amylin Pharmaceuticals (NASDAQ:AMLN)
Amylin Pharmaceuticals, Inc. (Amylin) is a biopharmaceutical company focusing on the diabetes and other metabolic diseases through the discovery, development and commercialization of medicines. It markets two medicines to treat diabetes, BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection. It is also markets a diabetes treatment, BYDUREON (exenatide extended-release for injectable suspension). BYDUREON is an extended-release medication for type 2 diabetes that provides continuous glycemic control in a once-weekly dose. Amylin maintains a research and early development program focused on peptide and protein therapeutics. It has also entered into alliances and business initiatives, including its relationship with Biocon, Limited (Biocon) to develop pharmaceutical products, including AC165198, a peptide hybrid drug candidate for diabetes, which was developed from its phybrid technology platform. In August 2012, Bristol-Myers Squibb Company acquired the Company.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Amylin Pharmaceuticals (NASDAQ:AMLN) Frequently Asked Questions
What is Amylin Pharmaceuticals' stock symbol?
Amylin Pharmaceuticals trades on the NASDAQ under the ticker symbol "AMLN."
Who are some of Amylin Pharmaceuticals' key competitors?
Some companies that are related to Amylin Pharmaceuticals include Johnson & Johnson (JNJ), Novartis (NVS), UnitedHealth Group (UNH), Pfizer (PFE), Roche (ROG), AbbVie (ABBV), Merck & Co., Inc. (MRK), Amgen (AMGN), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Abbott Laboratories (ABT), GlaxoSmithKline (GSK), Eli Lilly and (LLY), Thermo Fisher Scientific (TMO), AstraZeneca (AZN), Sanofi (SAN), Bayer (BAYN) and CSL (CSL).
How do I buy Amylin Pharmaceuticals stock?
Shares of Amylin Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Amylin Pharmaceuticals?
Amylin Pharmaceuticals' mailing address is 9360 Towne Centre Dr, SAN DIEGO, CA 92121-3057, United States. The biopharmaceutical company can be reached via phone at +1-858-5522200.
MarketBeat Community Rating for Amylin Pharmaceuticals (AMLN)MarketBeat's community ratings are surveys of what our community members think about Amylin Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Amylin Pharmaceuticals (NASDAQ:AMLN) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Amylin Pharmaceuticals (NASDAQ:AMLN) Earnings History and Estimates Chart
Amylin Pharmaceuticals (NASDAQ AMLN) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Amylin Pharmaceuticals (NASDAQ:AMLN) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Amylin Pharmaceuticals (NASDAQ:AMLN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Amylin Pharmaceuticals (NASDAQ AMLN)
No insider trades for this company have been tracked by MarketBeat.com
Amylin Pharmaceuticals (NASDAQ AMLN) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Amylin Pharmaceuticals (NASDAQ:AMLN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Amylin Pharmaceuticals (NASDAQ:AMLN) Income Statement, Balance Sheet and Cash Flow Statement
Amylin Pharmaceuticals (NASDAQ AMLN) Stock Chart for Sunday, February, 25, 2018